Revance Therapeutics Executive Salaries | Comparably
Revance Therapeutics Claimed Company
Revance Therapeutics is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions. read more
EMPLOYEE
PARTICIPANTS
21
TOTAL
RATINGS
250
HR or Marketing? Claim Your Free Employer Account

Revance Therapeutics Executive Salaries

Key Executives

Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Mark Foley  CEO / President
CEO / President
-
-
Chief Financial Officer, Chief Business Officer and Secretary
$430k
$1.54M
Chief Operating Officer
$640k
$1.41M

The average Revance Therapeutics executive compensation is $245,676 a year. Revance Therapeutics' highest paid executives include: Lauren Silvernail $1,544,396 and Abhay Joshi Ph.D., M.B.A. $1,407,475.

The median estimated compensation for executives at Revance Therapeutics including base salary and bonus is $242,947, or $116 per hour.

Last updated months ago.

$100k
$165k
$230k
$400k
$500k
$790k
$245,676*
Average Compensation
$242,947*
Median Compensation

* Estimated salaries Estimated salaries are based on data provided anonymously by employees and/or estimated by other statistical methods.

×
Rate your company